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Purpose: The aim of this study was to identify the presence of collagen-binding integrin subunits in human scleral
fibroblasts (HSFs) and investigate their actual functions in maintaining the mechanical creep properties of the HSFs-
seeded collagen matrix.
Methods: Primary HSFs were cultured in vitro. Reverse- transcription PCR was used to detect mRNA expression of
integrin α1, α2, and β1 subunits in HSFs. In addition, western blot analysis and immunofluorescence were used to detect
their protein in HSFs. Monoclonal antibodies were applied directly against the extracellular domains of integrin subunits
in HSFs cultured in the three-dimensional collagen gels to block the interaction between HSFs and the extracellular
collagen matrix. The effects of anti-integrin antibodies on HSFs morphology in collagen gel were observed. The effects
of the added antibodies on fibroblast-mediated collagen gels’ contraction were evaluated. Furthermore, the changes in
mechanical creep properties of collagen gel were measured by a biomechanics test instrument.
Results: The mRNA and protein expressions of collagen-binding integrin α1, α2, and β1 subunits were present in HSFs.
The elongated bipolar cells converted to spherical shapes after 6 h after the addition of integrin α1β1 and α2β1 antibody.
The blocking of integrin α1β1 and α2β1 subunits noticeably decreased the contraction in the collagen gels. In addition,
all samples were subjected to a constantly applied load of 0.03 N for 600 s. The blocking of integrin α1β1 and α2β1
subunits also induced increases in the values of final extension, creep extension, and creep rate, compared to those of the
controls (p<0.01). Furthermore, the creep elements were significantly increased with the augmentation of the integrin
antibody dose (p<0.01). The final extension of the integrin α2β1 antibody (1 μg/ml or 4 μg/ml) group was significantly
higher compared to that of the integrin α1β1 antibody (1 μg/ml or 4 μg/ml) group (p<0.01). However, the creep extension
and creep rate of the integrin α2β1 antibody (1 μg/ml or 4 μg/ml) group were not significantly different from those in the
integrin α1β1 antibody (1 μg/ml or 4 μg/ml) group (p>0.05).
Conclusions: Our findings suggested that HSF integrin α1β1 and α2β1 participated in maintaining the mechanical creep
properties of the HSFs-seeded collagen matrix. Furthermore, integrin α2β1 might play a more crucial role in maintaining
the mechanical creep properties of the collagen matrix than does integrin α1β1.
Myopia is a common ocular problem that affects perhaps
one billion people worldwide [1].Most myopia is produced by
lengthening of the ocular globe [2]. Much study has shown
that the axial eye length can change with intraocular pressure
(IOP). Congenital glaucomatous eyes show an increased axial
eye length, whereas decreased axial eye length with lowered
IOP is seen after trabeculectomy [3-5]. Given the evidence,
progressive myopia is thought to result from an inherited
biomechanical weakness of the sclera that allows it to stretch
(creep) in response to stress [6]. Further evidence suggests that
the  biomechanical  properties  of  the  sclera  may  play  a
significant regulatory role in the axial elongation of myopic
eyes. Creep describes the slow, time-dependent extension (or
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compression) of a sample of material when a constant load is
applied (i.e., extension versus time). Studies of changes in the
creep  properties  of  sclera  in  myopic  eyes  imply  that  the
posterior sclera from tree shrew eyes with induced myopia has
a  higher  creep  rate  than  does  that  from  normal  eyes.  In
contrast, samples from eyes recovering from induced myopia
have decreased creep rates. Moreover, creep rate appears to
be modulated in parallel with increased and decreased rates
of axial elongation, which indicates that the regulation of the
time-dependent mechanical properties of fibrous mammalian
sclera plays a role in controlling the axial elongation rate [7,
8]. Numbers of articles have demonstrated that the sclera is
not a static container of the eye, but rather is a dynamic tissue,
capable of altering the composition of the extracellular matrix
(ECM) and its biomechanical properties to regulate ocular
size and refraction [1,9,10].
Integrins are a large family of heterodimeric membrane
glycoproteins that play important roles in numerous cellular
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1334processes  involving  cell-ECM  and  cell-cell  interactions.
Integrins  consist  of  one  α  and  one  β  subunit  forming  a
noncovalently  bound  heterodimer.  Integrins  have  an
additional inserted domain (αI domain) in their α subunit. Four
out of the nine αI containing integrins, namely α1β1, α2β1,
α10β1, and α11β1, are receptors for collagens [11]. Collagen-
binding  integrins  were  reported  to  play  a  crucial  role  in
maintaining the structural and mechanical properties of the
collagen  matrix  in  skin  tissues  [12].  Previous  studies
suggested that collagen-binding integrins might be involved
in  the  development  of  myopia  [13,14].  However,  little
information is available concerning integrin expression in the
sclera, especially in human sclera. Furthermore, it is unclear
how  integrins  participates  in  maintaining  the  ECM’s
mechanical properties. This fact encouraged us to examine the
presence  of  major  collagen-binding  integrin  subunits  in
human  scleral  fibroblasts  (HSFs)  and  to  investigate  the
relationship  of  the  interaction  between  HSFs  and  the
extracellular collagen matrix with contraction and mechanical
creep properties of HSF-seeded collagen gel.
In the present study, we evaluated the expressions of
collagen-binding integrin subunits in HSFs and their role in
maintaining the creep properties of the collagen matrix, in an
attempt to highlight the actual functions of collagen-binding
integrin subunits in HSF-ECM interactions.
METHODS
Tissue  source:  This  study  was  approved  by  the  Ethics
Committee of Sun Yat-sen University (Guangzhou, China)
and it complied with the tenets of the Declaration of Helsinki
for biomedical research involving human tissue. Five healthy
human  eyes  from  donors  (age  range:  18–23  years)  were
obtained from the Eye Bank of the Zhongshan Ophthalmic
Center (Sun Yat-sen University). All procedures related to
animal operations in this study followed the Guide for the Care
and Use of Laboratory Animals of the USA National Institutes
of Health.
Human  scleral  fibroblast  isolation,  culture,  and
identification: As previously described, primary HSFs were
isolated  from  human  donor  eyeballs  [15].  The  cells  were
cultured in growth medium consisting of Dulbecco’s modified
Eagle's medium plus Ham’s nutrient mixture F-12(DMEM/
F12; Gibco, Grand Island, NY), 10% (v/v) fetal bovine serum,
100 U/ml penicillin/streptomycin (Invitrogen Corp, Carlsbad,
CA).  The  cells  were  incubated  at  37  °C  in  a  5%  CO2
humidified incubator and media was changed twice a week.
After reaching near confluence, the cells were subcultured at
a split ratio of 1:3. Fibroblasts from the third passage to the
sixth passage were used in this study.
Reverse transcription-polymerase chain reaction: Reverse-
transcription PCR was used to confirm the presence of specific
mRNAs  in  human  scleral  fibroblasts.  Total  RNA  was
extracted from the fibroblasts with Trizol reagent (Invitrogen
Life Technologies, Grand Island, NY) and confirmed using
spectrophotometry and agarose gel electrophoresis. The RT
step was performed at 42 °C for 60 min in a 20 μl solution
containing 2.5 μg RNA, M-MLV 5× reaction buffer, 20 U of
RNase Inhibitor, 0.5 μg oligo (dT) 18 primer, 1 mM dNTP
Mix, and 200 U RNase-free reverse transcriptase according to
the  manufacturer’s  instructions  (Fermentas,  Burlington,
Canada). The nucleotide sequences of the primers used in the
experiments  and  the  GenBank  accession  number  of  the
underlying sequences were denoted in Table 1. Each PCR was
performed  in  a  25  μl  solution  containing  1  μl  reverse-
transcription reaction products, 2.5 μl 10× EX Taq buffer,
0.2 mM dNTP Mix, 10 pmol of upstream primer, 10 pmol of
downstream  primer  and  2.5  U  Taq  DNA  polymerase
according to the manufacturer’s instructions (TaKaRa, Kyoto,
Japan). The PCR program was 3 min at 95 °C, followed by 25
cycles of 30 s at 94 °C, 45 s at 60 °C (α1 and β1) or 55 °C
(α2), and 45 s at 72 °C, followed by a final extension of 10
min  at  72  °C  in  a  thermocycler  (Whatman  Biometra,
Goettingen,  Germany).  The  PCR  product  was
electrophorezed  on  2%  agarose  gels  containing  1  μg/ml
ethidium bromide and then photographed under ultraviolet
illumination  (Alpha  Innotech  Corp,  Santa  Clara,  CA).  A
standard DNA ladder was used as a size marker. Furthermore,
the PCR products were sequenced (ABI 3730XL; Applied
Biosystems, Carlsbad, CA).
Indirect  immunofluorescence:  The  HSFs  were  grown  on
slides in six-well plates until 70%–80% confluence occurred.
The slides were fixed in 4% formaldehyde for 30 min at 4 °C
after washed in PBS for three times and air-dried. The slides
were washed with PBS three times again, covered with 10%
normal goat serum diluted in PBS, and incubated for 20 min
at 37 °C. The slides were then incubated at 4 °C overnight
with the primary antibodies (anti-integrin α1, anti-integrin
α2, and anti-integrin β1; Millipore Biotechnology, Billerica,
MA) diluted at 1:100 in PBS. Controls for immunospecificity
were included in all experiments, except PBS replaced the
primary antibody. After washed with PBS, the slides were
TABLE 1. PRIMERS USED FOR REVERSE TRANSCRIPTION-PCR AMPLIFICATION OF HUMAN INTEGRIN SUBTYPES.
Gene product GenBank accession Forward primer (5′-3′) Reverse primer (5′-3′) Product size
(bp)
integrin α1 NM_181501.1 TCAAACGAGGCACAATTCTG AGCAGGATGACCCATAATGG 280
integrin α2 NM_002203.3 GCCTTGCCTTAGGTAATCAG CCAGGAATGCTGCTAAACAT 226
integrin β1 NM_033668.2 GAAAGACACATGCACACAGGAA ACATGAACCATGACCTCGTTGT 180
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1335exposed to fluorescein isothiocyanate-conjugated (FITC) goat
anti-mouse IgG antibodies diluted at 1:50 in PBS at 37 °C for
30 min. Then hoechst 33358 was added into slides for 5 min
to stain the cell nucleus. Immunofluorescent images were
taken using a confocal microscope (LSM 510 META, Carl
Zeiss, Jena, Germany).
Western blotting analysis: The monoclonal antibodies against
integrin  α1,  α2,  and  β1  were  obtained  from  Millipore
Biotechnology (Billerica, MA). The cells were lysed in ice-
cold  modified  radioimmunoprecipitation  (RIPA)  buffer  at
4 °C for 30 min. Cell lysates were centrifuged at 13,000× g
for  10  min  to  remove  insoluble  material.  Protein
concentrations were determined using the BCA method. Of
the supernatant, 10 μg and 20 μg of each protein sample were
separated  by  12%  sodium  dodecylsulfate-PAGE  (SDS–
PAGE)  and  subsequently  blotted  onto  polyvinylidene
difluoride (PVDF) membranes (100 V for 1 h; Millipore), and
the membranes were blocked in 5% fat-free milk (Santa Cruz
Biotechnology, Santa Cruz, CA) at room temperature for 2 h
while rocking. Membranes were incubated with anti-integrin
α1, anti-integrin α2, and anti-integrin β1 in an incubation
buffer containing 5% BSA overnight at 4 °C while rocking,
after  washing  three  times  with  TBST  (Tris-base,  sodium
chloride,  and  Tween-20).  The  binding  of  the  primary
antibodies  was  revealed  by  horseradish  peroxidase-
conjugated secondary antibodies (Santa Cruz Biotechnology,
Santa  Cruz,  CA).  The  proteins  of  the  membranes  were
detected  using  an  enhanced  chemiluminescence
immunoblotting detection system (Thermo Fisher Scientific,
Rockford, IL) and the film was scanned.
Preparation of collagen gels and contraction assay: Type I
collagen was extracted by stirring adult rat tail tendons (from
Sprague Dawley rats) for 48 h at 4 °C in a sterile 0.1% (vol/
vol) acetic solution (300 ml for 1 g of collagen), and the
resulting solution was centrifuged at 16,000× g for 1 h at 4 °C
and stored at 4 °C [16].
In summary, HSFs were resuspended at 1×105 cells/ml in
DMEM/F12 (5% fetal bovine serum) containing 2 mg/ml
collagen type I neutralized with 1 M NaOH. Monoclonal
antibodies,  each  of  which  binds  specifically  to  the
extracellular binding domain of α1, α2, or β1 subunits, were
purchased from Millipore Biotechnology. For the inhibition
studies, anti-integrin monoclonal antibodies (α1+β1, α2+β1)
or  mouse  anti-human  IgG  as  controls  (Invitrogen  Life
Technologies, Grand Island, NY) were incubated with the
cells for 15 min at 37 °C, before their addition to the collagen
solution. The anti-integrin monoclonal antibodies were used
in the experiments at final concentrations of 1 μg/ml or 4 μg/
ml  and  mouse  anti-human  IgG  were  used  at  final
concentrations  of  0.1  mg/ml.  Mixture  samples  of  2  ml
including HSFs, antibodies, and collagen solution were cased
in the 12-well plates (Corning, Lowell, MA). These plates
were pre-coated with sterile BSA (2% in PBS) overnight at
4  °C  and  were  washed  in  sterile  PBS  before  the  studies.
Following collagen polymerization for 1 h at 37 °C, the edges
of the HSFs-seeded collagen gels were detached from the
sides of the wells to give a floating gel, and culture medium
that  contained  the  propotional  anti-integrin  monoclonal
antibodies or mouse anti-human IgG was added. The culture
medium  was  changed  every  other  day  and  the  gels  were
incubated in culture medium at 37 °C for 72 h. The wells were
photographed at 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, 48 h, and 72 h.
The surface area of the gels was determined by quantitative
morphometry with Image-pro plus 5.0 (Media Cybernetics,
Bethesda, MD) from the prints. The contracted surface area
was expressed as a percentage of the initial area.
Mechanical properties measured: To evaluate the mechanical
properties of collagen gels, creep tests were performed at
room temperature in air using dynamic mechanical analysis
of materials and devices (ElectroForce 3200 test instrument;
Bose Corporation, Eden Prairie, MN) on day 3. A double-
bladed  knife  was  used  to  cut  3  mm-wide  by  5  mm-long
collagen gel samples. In creep mode, a constant stress was set
at 0.03 N for 600 s. Dynamic mechanical analysis was used
to apply small, steadily maintained loads to collagen samples
and to monitor the resultant extension over time. The 0.03 N
load  was  applied  gradually  (0–0.03  N  in  20  s)  and  held
constant for 600 s while sample length was monitored. After
application of the 0.03 N load, the rate of change of length of
the samples took some time to stabilize. The extension at 600
s was considered as the final extension. The slope of the curve
between 100 s to 600 s was taken as the creep rate. Creep rate
was expressed as the creep extension over 100–600 s (in
percent extension per hour).
Effects  of  anti-integrin  antibodies  on  human  scleral
fibroblasts morphology in collagen gel: Collagen solution
(1 ml) containing HSFs prepared as described above was
added to 24-well plates. After 24 h, a sufficient amount of fetal
bovine serum-containing medium was added, and the collagen
gel was gently detached from the dish to give a floating gel.
The medium was removed, and one or two drops of anti-
human integrin antibody solution (a mixture of anti-integrin
α1 and β1 antibodies or a mixture of anti-integrin α2 and β1
antibodies diluted to 4 µg/ml with serum-free Dulbecco’s
modified  Eagle's  medium)  were  added  directly  onto  the
collagen gel and mouse anti-human IgG (0.1 mg/ml) was as
controls.  Morphological  changes  of  fibroblasts  were
monitored with an inverted microscope (T-B2.5XA; Nikon,
Tokyo, Japan).
Statistical analysis: Every experiment was repeated at least
five times. Data was expressed as mean±standard deviation
(SD). Statistical analysis was performed with software (SPSS
version 13.0; SPSS, Chicago, IL) between two groups using
a two-tailed Students’ t-test for unpaired values, and p<0.05
was considered statistically significant.
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1336Figure 1. Identification of the collagen-binding integrins subtypes expressed in human scleral fibroblasts (HSFs). A: Amplification products
representing the integrin α1 (280 bp), integrin α2 (226 bp) and integrin β1 (180 bp) subunits were detected in HSFs using reverse-transcription
PCR. Molecular markers were included for product size comparison. B: The products representing the integrin α1 (130 kDa), integrin α2
(129 kDa), and integrin β1 (88 kDa) subunits were detected in HSFs using western blot analysis. C-K: Distribution of integrin α1, α2 and
β1 in HSFs were observed by indirect immunofluorescence. FITC marked the secondary antibody (green; 1) and Hoechst33358 dyed the
nucleus (blue; 2). The first (1) and second images (2) combined to form the third image (3). Integrin α1 (C-E), α2 (F-H), and β1 (I-K) were
localized in the plasmalemma of HSFs.
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The expression of integrin α1, α2, and β1 subtypes in human
scleral  fibroblasts:  Figure  1A  showed  that  the  mRNA
expression of collagen-binding integrin subtypes (α1, α2, and
β1) in HSFs was present. The predicted size of the products
amplified  by  the  PCR  primers  matched  the  size  of  the
individual  integrin  subtype.  Sequencing  the  amplicons
confirmed that they truly were the intended product. Western
blot  analysis  showed  the  presence  of  collagen-binding
integrin proteins (α1, α2, and β1) in HSFs. Integrin α1 was
detected as a 130 kDa band, integrin α2 as a 129 kDa band,
and integrin β1 as a 88 kDa band (Figure 1B). In the indirect
immunofluorescence,  the  fibroblasts  treated  with  anti-
primary antibodies showed green, and the nucleus showed
blue (Figure 1C). Results from these tests indicated that the
major collagen-binding integrins subtypes were present in the
plasmalemma of HSFs.
Effects  of  anti-integrin  antibodies  on  human  scleral
fibroblasts morphology in collagen gel: Initially, fibroblasts
incorporated in collagen lattices were spherical in shape. By
6 h, cells in the collagen gel elongated and spread. After 24 h,
all fibroblasts with elongated stellate/bipolar cell shapes were
observed  in  the  collagen  gels.  The  shape  changes  were
observed  within  several  minutes  after  the  addition  of  the
antibody (α1β1, α2β1). The elongated bipolar cells converted
to spherical shapes after 6 h (see Figure 2).
Contraction assay: In the control groups, contraction of the
gels became visible 2–6 h after gel casting, being maximal
between 12 h and 48 h, and reached a plateau at 72–80 h. Dose-
dependent anti-integrin monoclonal antibodies inhibition of
the  contraction  of  collagen  matrices  were  shown  as  a
percentage of the initial gel surface area at day 3 (Figure 3).
Mechanical creep properties of collagen matrix: Figure 4A
showed  typical  extension-versus-time  behavior  of  the
samples. Samples were subjected to a constantly applied load
of 0.03 N for 600 s. The extension at 600 s was considered as
the final extension. Prior to that was the extension’s nonlinear
phase (i.e., up to approximately 100 s), and the slope of the
later, near-linear phase (approximately 100–600 s).
As shown in Figure 4B, the final extensions of controls,
the integrin α2β1 antibody (1 μg/ml) group, and the integrin
α1β1  antibody  (1  μg/ml)  group  were  1.75±0.12  mm,
3.12±0.17 mm, and 2.66±0.13 mm, respectively. The final
extensions of the integrin α1β1 antibody (1 μg/ml) group and
integrin α2β1 antibody (1 μg/ml) group were significantly
higher than that in controls (p<0.01). Furthermore, the final
extension of the integrin α2β1 antibody (1 μg/ml) group was
significantly  greater  than  that  in  integrin  α1β1  antibody
(1 μg/ml) group (p<0.01). The final extensions of the integrin
α2β1 antibody (4 μg/ml) group and integrin α1β1 antibody
(4 μg/ml) group were 6.99±0.18 mm and 5.66±0.34 mm,
respectively. The final extension was significantly increased
with the augmentation of the integrin antibody dose (p<0.01).
Furthermore, the final extension of the integrin α2β1 antibody
(4 μg/ml) group was significantly higher, compared to that in
the integrin α1β1 antibody (4 μg/ml) group (p<0.01).
In  the  following  analyses,  we  considered  extension
during the near-linear phase (approximately 100–600 s) of the
relationship to be a stable measure of creep extension. To
isolate creep extension from the initial shorter-term changes
in length, the absolute length of each sample was determined
at 100 s after the load was applied. Creep extension (100–600
s) was computed as a percentage of this length. As shown in
Figure 4C, the creep extensions of the controls, the integrin
α2β1 antibody (1 μg/ml) group, and integrin α1β1 antibody
(1  μg/ml)  group  were  0.06±0.02%,  0.13±0.01%,  and
0.15±0.03%,  respectively.  The  creep  extensions  of  the
integrin  α2β1  antibody  (1  μg/ml)  group  and  the  integrin
Figure 2. Morphological changes caused by the addition of anti-human integrin antibodies to human scleral fibroblasts (HSFs) in the collagen
gel lattice. Anti-human integrin antibody (at the concentration 4µg/ml, which was diluted with serum-free DMEM) was added dropping it
onto an HSF-populated collagen gel. Morphological changes of fibroblasts were monitored after 6 h addition using light microscopy (original
magnification 200×). A: mouse anti-human IgG (0.1 mg/ml) was used as a control; B: A mixture of anti-human integrin a1 (4 µg/ml) and
anti-human integrin β1 (4 µg/ml) antibodies were added. C: A mixture of anti-human integrin a2 (4 µg/ml), and anti-human integrin β1 (4
µg/ml) antibodies were added.
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1338α1β1 antibody (1 μg/ml) group were significantly higher than
that of the controls (p<0.01). The creep extensions of the
integrin α2β1 antibody (4 μg/ml) group and integrin α1β1
antibody (4 μg/ml) group were 0.29±0.02% and 0.26±0.01%,
which was significantly increased with the augmentation of
the  integrin  antibody  dose  (p<0.01).  However,  the  creep
extension  of  the  integrin  α2β1  antibody  group  was  not
significantly different from that of the integrin α1β1 antibody
group, regardless of low or high doses (p>0.05).
Creep rate was computed as percent extension per hour.
As shown in Figure 4D, the creep rate of controls, the integrin
α2β1  antibody  (1  μg/ml)  group,  and  the  integrin  α1β1
antibody (1 μg/ml) group were 0.44±0.15%/h, 0.91±0.09%/h,
and  1.05±0.18%/h,  respectively.  The  creep  rates  of  the
integrin α2β1 antibody (1 μg/ml) group and integrin α1β1
Figure 3. Gel contraction was dose-dependent inhibited by anti-integrin α1β1 and α2β1 antibody. Human fibroblasts were incubated in the
absence (mouse anti-human IgG as control) or presence of a combination of anti-human integrin α and anti-human integrin β1 antibodies at
final concentrations of 1 µg/ml and 4 µg/ml for 3 days. A: Representative photomicrographs show collagen gel changes. B: Contraction was
indicated as percentage of the initial gel surface area.
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1339antibody (1 μg/ml) group were significantly higher than that
of the controls (p<0.01). The creep rates of the integrin α2β1
antibody  (4  μg/ml)  group  and  the  integrin  α1β1  antibody
(4  μg/ml)  group  were  2.08±0.16%/h  and  1.90±0.07%/h,
which were significantly increased with the augmentation of
the integrin antibody dose (p<0.01). There was no significant
difference in the creep rate between the integrin α2β1 antibody
and integrin α1β1 antibody groups, regardless of low or high
doses (p>0.05).
DISCUSSION
Previous  studies  found  that  fibroblasts  can  condense  a
hydrated collagen lattice to a tissue-like structure, which can
mimic the real environment in vivo, allowing study of the
underlying mechanisms resulting from cell-ECM interaction
[16].  This  phenomenon  is  thought  to  be  related  to  tissue
remodeling [17]. The sclera tissue contains approximately
90% collagen by weight, consisting predominantly of type I
collagen in mammals. Therefore, HSFs were provided with a
three-dimensional matrix consisting of collagen type I, to
elucidate the underlying mechanisms resulting from HSF and
ECM  interaction.  Furthermore,  by  using  the  monoclonal
antibodies  of  the  major  integrin  to  block  the  interaction
between the ECM and HSFs, we evaluated, for the first time,
the quantitative changes in the creep properties of collagen
gels with HSFs seeded in.
Integrins could have a pivotal effect on the interaction of
HSFs and ECM, which regulate the mechanical properties of
HSFs-seeded  collagen  matrix.  Integrins  α10β1  and  α11β1
have been discovered quite recently, and seem to be involved
in  bone  and  cartilage.  Their  functions  are  not  quite  clear
[11]. The role of the α1β1 and α2β1 integrins as the major
cellular  collagen  receptors  in  fibroblasts  has  been  well
documented  [11,18,19].  Thus,  the  present  study  was
undertaken to elucidate the expression of integrin α1, α2, and
β1 in HSFs. In previous animal studies, the α1, α2, and β1
subunit  expression  decreased  during  the  development  of
myopia, which showing that they may have positive regulator
roles  in  the  biomechanical  remodeling  that  accompanies
myopic eye growth [13]. By blocking interactions between
Figure 4. Anti-integrin a2β1 and anti-integrin a1β1 affect on mechanical creep properties of collagen matrix. A: Typical extension-versus-
time behavior of the samples was shown, respectively. A constantly applied load of 0.03 N for 600 s was subjected to each sample. B: Anti-
integrin a2β1 and anti-integrin a1β1 acted on the final extension of the HSF-populated collagen gel. C: Anti-integrin a2β1 and anti-integrin
a1β1 acted on creep extension of the HSF-populated collagen gel. D: Anti-integrin a2β1 and anti-integrin a1β1 acted on the creep rate of the
HSF-populated collagen gel. Results were expressed as mean±SEM *p<0.01 versus CON; #p<0.01 versus α2β1 (1 μg/ml) or α1β1 (1 μg/ml);
†p<0.01 versus α1β1 (1 μg/ml) or α1β1 (4 μg/ml).
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1340collagen  and  HSFs  with  anti-integrin  α1β1  and  α2β1
antibodies, we focused on the changes in the contraction and
the mechanical creep properties of the collagen, which are
involved in the sclera remodeling related to myopia [7,8]. In
all  cases,  the  inhibition  of  gel  contraction  was  correlated
directly with integrin antibody concentration, suggesting that
inhibition of collagen contraction is a specific effect caused
by these integrin antibodies. The blocking of integrin α1β1
and α2β1 subunits induced increases in the values of final
extension, creep extension, and creep rate, which reflected the
creep elements of the collagen matrix. This was similar to an
investigation that enhanced contraction result in the higher-
strength  collagen  gels  [17].  These  changes  in  collagen
contraction  and  mechanical  properties  suggested  that  the
interactions between HSFs and collagen via integrins α1β1
and α2β1 regulated the mechanical properties of HSFs-seeded
collagen matrix in vivo.
Similar  differences  between  the  functions  of  integrin
α1β1 and α2β1 heterodimers in vitro have also been described.
Integrin α1β1 was reported to regulate collagen synthesis and
promote  cell  growth  [20],  whereas  integrin  α2β1  was  a
functional  cellular  receptor  for  type  I  collagen  fibrils,
mediating collagen gel contraction and regulating MMP-1
expression  [21-23].  In  our  study,  the  inhibitions  of  the
collagen gels’ contraction were more obvious from blocking
interactions between collagen and HSFs with anti-integrin
α2β1  antibodies  than  doing  so  with  anti-integrin  α1β1
antibodies.  Furthermore,  the  blocking  of  integrin  α2β1
subunits induced more significant increases in the values of
final extensions, compared to the blocking of integrin α1β1
subunits. Our data suggested that α2β1 integrins in HSFs
might be the major receptors responsible for regulating ECM
remodeling.
Several  studies  have  shown  that  antibodies  against
integrin inhibit cells from attaching to collagen type I [13,
14,24-26]. In our study, the elongated bipolar cells converted
to spherical shapes after the addition of the antibodies (α1β1
and α2β1). The morphological changes in HSFs indicated that
the blocking of integrin subunits resulted in the detachment
of fibroblasts from collagen, and that then the changes in
mechanical properties might occur in vivo.
Based on the results of the present study, we consider
human  collagen  matrix  remodeling  might  be  regulated
through cell attachment to matrix molecules by integrin. The
HSFs  were  inhibited  from  attaching  to  the  collagen  by
blocking  the  collagen-binding  integrins,  so  that  the
contraction of collagen matrices was inhibited, then collagen
matrices  lost  their  network  structure  and  the  mechanical
proprieties changed. The present results might serve to explain
the important observations that the integrin α1, α2, β1 subunits
expression in sclera decreased during the development of
myopia. That is, the sclera might become more extensible,
resulting in its inability to resist the mechanical forces exerted
by IOP. The eye thereby became longer, resulting in an axial
myopia.
In summary, our present work provides evidence that the
interactions between fibroblasts and collagen via integrins
α1β1 and α2β1 regulate the mechanical creep properties of
collagen matrix. Our data also underscore the possibility that
α2β1 integrins in HSFs might be the major subunit responsible
for regulating ECM remodeling. Further studies are needed to
elucidate  the  exact  role  of  collagen-binding  integrins  in
myopia.
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